World Hepatitis Day – European Medicines Agency uses regulatory tools to facilitate patient access to innovative medicines

View source ↗

Summary

EMA highlights use of regulatory tools to improve timely patient access to innovative medicines for hepatitis on World Hepatitis Day.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis